Infertility Treatment Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Infertility Treatment Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The infertility treatment devices market is poised to grow at a CAGR of 5.43 % during the forecast period.

COVID had a significant impact on the studied market. Various studies and articles have been published on the impact of COVID on in vitro fertilization (IVF). For instance, a Human Fertilization & Embryology Authority article titled "Impact of COVID-19 on fertility treatment 2020" stated that on April 15, 2020, fertility treatments and other elective medical procedures were suspended throughout the United Kingdom due to COVID-19's effects on the National Health Service (NHS). In the UK, the percentage of IVF procedures covered by the NHS fell from 35% in 2019 to 28% in 2020. IVF cycle declines differed among the four countries, with Wales experiencing a 39% decline from 2019 to 2020 compared to England's 19% decline. Similarly, according to a research report published in February 2021 and titled "Impact of COVID-19 on female fertility: a comprehensive review and meta-analysis protocol," SARS-CoV-2 is alleged to interfere with ART operations and disrupt female fertility via controlling ACE2. Consequently, it was anticipated that the pandemic would have an impact on market growth; however, with the decline in COVID-19 cases and widespread vaccination, it is anticipated that the studied market will once again reach its full potential over the forecast period.

The major factors attributing to the growth of the Infertility Treatment Devices market are significant changes in lifestyle which contributed to the rise in infertility and prevalence of conditions such as Polycystic Ovary Syndrome (PCOS). Also, a constant increase in the incidence of infertility in both sexes is projected to drive the market. According to a Eurostat post titled "Fertility statistics" from April 2022, developed nations consider a total fertility rate of about 2.1 live births per woman to be the replacement level. In contrast to 2019, when it was 1.53, the EU's overall fertility rate in 2020 was 1.50 live births per woman. With 1.83 live births per woman, France had the highest total fertility rate among EU members in 2020, followed by Romania (1.80 live births per woman) and Czechia (1.71 live births per woman). In comparison, Malta (1.13 live births per woman), Spain (1.19 live births per woman), and Italy had the lowest total fertility rates in 2020. (1.24 live births per woman). Hence, a low fertility rate would increase the demand for in vitro fertilization and will increase market growth. Thus, the abovementioned factors are expected to increase market growth.

However, the lack of availability to people due to the higher cost of IVF procedures and the possible risk of the baby being born with birth defects, risks of infections, and unfavorable scarring are expected to hinder the market growth.

Key Market TrendsFertility Clinics Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Factors such as increasing success rate, product launches and opening of new facilities are expected to increase the market growth. Due to the high procedure success rate and ongoing improvement, the studied market is anticipated to have a sizable proportion of the market under study. For instance, according to a July 2021 article titled "Growth Trajectory Of Fertility Segment In India," between 2 and 2.5 lac IVF procedures are performed in India each year, and the fertility market may experience 20% compound annual growth over the past five years. In-vitro fertilization is therefore anticipated to experience significant expansion during the predicted period. Similarly, product launches are expected to increase segment growth as advanced products available in fertility clinics are expected to increase the footfall in the facility. In May 2022, Cook Medical launched the next-generation MINC+ benchtop incubator in the United States and Canada. The latest version of MINC incorporates the DishTrace platform, which combines capabilities for a variety of dish-data management tools through the touchscreen interface and a PC software program. With DishTrace, users may monitor up to 50 MINC+ incubators, follow culture dishes as they are checked in and out of the incubator, access, and log information through the system's touchscreen, and generate and view graphical histories and reports of MINC+ activities. Similarly, the launch of fertility clinics is another factor in the growth of the market. For instance, Sakra World Hospital began offering infertility treatments in September 2021, creating personalized treatment regimens for each patient. Such factors would spur market expansion in the near future. Thus, the abovementioned factors are expected to increase the market growth.

North America is Expected to Dominate the Market Over the Forecast Period

The North America region is expected to hold a major market share in the studied market due to increasing infertility and the need for external support in the region. 33% of Americans have used or know someone who has used fertility treatments, according to a September 2021 article in CoFertility Inc. Only 12% of women have trouble getting pregnant or carrying a baby to term. In America, 1 in 8 couples struggles with infertility. After a year of unprotected sex, 12–15% of all couples are unable to get pregnant. After two years of unprotected sex, 10% of all couples are unable to get pregnant. 33% of Americans have used or are aware of using fertility treatments. As a result, the market will continue to expand favorably. The same source stated that more women than ever are turning to the medical community for help having a baby. As much as 85% to 90% of infertility cases are treated with conventional medical therapies such as medication or surgery. Awareness programs in the region are another factor in market growth. For instance, in its capacity as an official sponsor of National Infertility Awareness Week 2022, Progyny, Inc., a top benefits management company in the US that specializes in fertility and family-building benefits solutions, and RESOLVE: The National Infertility Association announced that both groups rang the Nasdaq Stock Market Opening Bell on Tuesday, April 26, 2022. National Infertility Awareness Week highlights the vast effects of infertility and the struggle that millions of people face in starting a family. Progyny and RESOLVE want to eliminate the stigmas and obstacles preventing people from starting children since one in eight American couples struggle with infertility. Similarly, in April 2022, Inception Fertility initiated "The Faces of Fertility," a campaign to highlight the multidisciplinary team of specialists within Inception's clinical network who use education, science and technology, lab skills, and a compassionate approach to providing exceptional care throughout each patient's journey, in honor of National Infertility Awareness Week. Thus, the abovementioned factors are expected to increase the market growth.

Competitive Landscape

The infertility treatment devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions with other companies to consolidate their market positions across the globe and while others are distributing products. Some of the major players in the market are CooperSurgical Inc, Hamilton Thorne Inc, Dxnow, Cook Medical Inc, and Vitrolife among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.